JP2009503104A5 - - Google Patents

Download PDF

Info

Publication number
JP2009503104A5
JP2009503104A5 JP2008525187A JP2008525187A JP2009503104A5 JP 2009503104 A5 JP2009503104 A5 JP 2009503104A5 JP 2008525187 A JP2008525187 A JP 2008525187A JP 2008525187 A JP2008525187 A JP 2008525187A JP 2009503104 A5 JP2009503104 A5 JP 2009503104A5
Authority
JP
Japan
Prior art keywords
composition
modified nanoparticles
solid material
powder
bulk solid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008525187A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009503104A (ja
JP5694643B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/030278 external-priority patent/WO2007019229A1/en
Publication of JP2009503104A publication Critical patent/JP2009503104A/ja
Publication of JP2009503104A5 publication Critical patent/JP2009503104A5/ja
Application granted granted Critical
Publication of JP5694643B2 publication Critical patent/JP5694643B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008525187A 2005-08-05 2006-08-04 改善された流動性を示す組成物 Expired - Fee Related JP5694643B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70582105P 2005-08-05 2005-08-05
US60/705,821 2005-08-05
PCT/US2006/030278 WO2007019229A1 (en) 2005-08-05 2006-08-04 Compositions exhibiting improved flowability

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013027433A Division JP2013100352A (ja) 2005-08-05 2013-02-15 改善された流動性を示す組成物

Publications (3)

Publication Number Publication Date
JP2009503104A JP2009503104A (ja) 2009-01-29
JP2009503104A5 true JP2009503104A5 (enExample) 2009-09-24
JP5694643B2 JP5694643B2 (ja) 2015-04-01

Family

ID=37311861

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008525187A Expired - Fee Related JP5694643B2 (ja) 2005-08-05 2006-08-04 改善された流動性を示す組成物
JP2013027433A Pending JP2013100352A (ja) 2005-08-05 2013-02-15 改善された流動性を示す組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013027433A Pending JP2013100352A (ja) 2005-08-05 2013-02-15 改善された流動性を示す組成物

Country Status (7)

Country Link
US (1) US8062670B2 (enExample)
EP (1) EP1917301B1 (enExample)
JP (2) JP5694643B2 (enExample)
CN (1) CN101243130B (enExample)
AU (1) AU2006278571B2 (enExample)
CA (1) CA2617909C (enExample)
WO (1) WO2007019229A1 (enExample)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
JP4681231B2 (ja) 2002-03-20 2011-05-11 マンカインド コーポレイション 吸入装置
US7638138B2 (en) * 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
USRE45404E1 (en) 2003-03-27 2015-03-03 Shin Nippon Biomedical Laboratories, Ltd. Powder medicine applicator for nasal cavity
WO2006016530A1 (ja) * 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
ATE486064T1 (de) 2004-08-20 2010-11-15 Mannkind Corp Katalyse der diketopiperazinsynthese
HUE025151T2 (en) 2004-08-23 2016-01-28 Mannkind Corp Diceto-piperazine salts for drug delivery
MX373000B (es) 2005-09-14 2020-05-21 Mannkind Corp Metodo para formulacion de farmaco basado en el aumento de la afinidad de agentes activos hacia las superficies de microparticulas cristalinas.
CN104383546B (zh) 2006-02-22 2021-03-02 曼金德公司 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
US20080071141A1 (en) * 2006-09-18 2008-03-20 Abhisuek Gattani Method and apparatus for measuring attributes of an anatomical feature during a medical procedure
KR101432853B1 (ko) * 2006-12-21 2014-08-26 쓰리엠 이노베이티브 프로퍼티즈 컴파니 나노입자의 제조 방법
ES2652415T3 (es) * 2006-12-26 2018-02-02 Shin Nippon Biomedical Laboratories, Ltd. Preparación para aplicación transnasal
CN101113078B (zh) * 2007-07-10 2011-02-02 程道远 新型玻璃防霉隔离粉
JP2011508019A (ja) * 2007-12-21 2011-03-10 スリーエム イノベイティブ プロパティズ カンパニー 混合型配位子表面改質ナノ粒子
DE102008020701A1 (de) * 2008-04-24 2009-10-29 Bayer Technology Services Gmbh Formulierung mit reduzierter Hygroskopizität
WO2009137595A2 (en) * 2008-05-08 2009-11-12 3M Innovative Properties Company Process for producing nanoparticles
EP2296628B1 (en) * 2008-05-22 2014-05-14 3M Innovative Properties Company Process for manufacturing flowable powder drug compositions
MY155524A (en) 2008-06-13 2015-10-30 Mannkind Corp A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
US9956170B2 (en) 2008-06-26 2018-05-01 3M Innovative Properties Company Dry powder pharmaceutical compositions for pulmonary administration, and methods of manufacturing thereof
EP2309984B1 (en) * 2008-07-02 2018-04-11 3M Innovative Properties Company Method of making a dry powder pharmaceutical composition
TWI494123B (zh) 2008-08-11 2015-08-01 Mannkind Corp 超快起作用胰島素之用途
US20100116172A1 (en) * 2008-11-13 2010-05-13 3M Innovative Properties Company Method for making a dispersion
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
WO2010077583A1 (en) 2008-12-30 2010-07-08 3M Innovative Properties Company Composite particles and method of forming
CN102272277A (zh) * 2008-12-30 2011-12-07 3M创新有限公司 润滑剂组合物及形成方法
US8538707B2 (en) 2009-03-11 2013-09-17 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9101539B2 (en) * 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
AU2010259943C1 (en) 2009-06-12 2016-03-03 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US20100323067A1 (en) * 2009-06-19 2010-12-23 Hershey Foods Corporation Temperature resistant chocolate composition and method
US20120100373A1 (en) 2009-06-26 2012-04-26 Shinbach Madeline P Method of milling particles with nanoparticles and milled free-flowing powder
US8827946B2 (en) 2009-07-31 2014-09-09 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
JP5784622B2 (ja) 2009-11-03 2015-09-24 マンカインド コーポレ−ション 吸入活動をシミュレートするための装置及び方法
EP2501646A4 (en) * 2009-11-20 2015-07-29 3M Innovative Properties Co INORGANIC PIGMENT COMPOSITIONS COMPRISING SURFACE-MODIFIED NANOPARTICLES AND METHODS OF MAKING SAME
JP5690352B2 (ja) 2009-11-20 2015-03-25 スリーエム イノベイティブ プロパティズ カンパニー 表面修飾ナノ粒子が共有結合した導電性粒子を含む組成物及びその製造方法
CN102639665B (zh) 2009-12-03 2015-04-01 3M创新有限公司 粒子的静电沉积方法、磨粒以及制品
EP2507320B1 (en) 2009-12-03 2020-05-27 3M Innovative Properties Company Method of inhibiting water adsorption of powder by addition of hydrophobic nanoparticles
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
WO2012047691A2 (en) 2010-10-04 2012-04-12 3M Innovative Properties Company Method of modifying dissolution rate of particles by addition of hydrophobic nanoparticles
JP6033233B2 (ja) * 2010-12-17 2016-11-30 スリーエム イノベイティブ プロパティズ カンパニー マルチサイズ粒子を有する転写物品及び方法
MX353285B (es) 2011-04-01 2018-01-05 Mannkind Corp Paquete de blister para cartuchos farmaceuticos.
CN102810377A (zh) * 2011-05-31 2012-12-05 深圳出入境检验检疫局食品检验检疫技术中心 一种复合型磁性纳米的制备方法及在小分子提取及富集中的应用
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
HK1201475A1 (en) 2011-10-24 2015-09-04 Mannkind Corporation Methods and compositions for treating pain
KR20140147891A (ko) 2012-04-13 2014-12-30 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 응집체 입자
AU2013289957B2 (en) 2012-07-12 2017-02-23 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
BR112015023168B1 (pt) 2013-03-15 2021-08-10 Mannkind Corporation Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina
BR122019026637B1 (pt) 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
EP3049059B1 (en) 2013-09-24 2021-11-03 Satsuma Pharmaceuticals, Inc. Intranasal dhe formulation for the treatment of headache
CN104644618A (zh) * 2013-11-19 2015-05-27 上海医药工业研究院 一种干粉吸入剂及其制备方法
EP3083840A1 (en) * 2013-12-19 2016-10-26 3M Innovative Properties Company Nanoparticle powder composition and method of making the same
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
JP6546386B2 (ja) * 2014-10-15 2019-07-17 株式会社アドマテックス 無機フィラー及びその製造方法、樹脂組成物、及び成形品
WO2016064405A1 (en) 2014-10-23 2016-04-28 3M Innovative Properties Company Composition of an insulating pvc substrate with nanoparticle treated filler
KR102406867B1 (ko) 2016-06-16 2022-06-13 쓰리엠 이노베이티브 프로퍼티즈 컴파니 나노입자 충전된 배리어 접착제 조성물
TWI617533B (zh) 2016-12-09 2018-03-11 財團法人工業技術研究院 表面改質陶瓷粉體及其應用
CA3067368A1 (en) 2017-06-16 2018-12-20 TenEx Technologies, LLC Compositions and methods for treating subterranean formations
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN111669978A (zh) * 2018-02-06 2020-09-15 日清富滋株式会社 马铃薯淀粉和马铃薯淀粉组合物
CN111886316B (zh) 2018-03-22 2021-07-09 3M创新有限公司 经电荷改性的粒子及其制备方法
WO2019180619A1 (en) 2018-03-22 2019-09-26 3M Innovative Properties Company Modified aluminum nitride particles and methods of making the same
CA3122396A1 (en) 2018-12-11 2020-06-18 Satsuma Pharmaceuticals, Inc. Compositions, devices, and methods for treating or preventing headaches
EP3785825A1 (en) 2019-08-30 2021-03-03 3M Innovative Properties Company Powder blend for use in additive manufacturing
CN111358773B (zh) * 2020-04-10 2021-03-30 广州南鑫药业有限公司 一种帕拉米韦干粉吸入剂及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2801185A (en) * 1952-05-16 1957-07-30 Du Pont Silica hydrosol powder
US4478876A (en) * 1980-12-18 1984-10-23 General Electric Company Process of coating a substrate with an abrasion resistant ultraviolet curable composition
US4455205A (en) 1981-06-01 1984-06-19 General Electric Company UV Curable polysiloxane from colloidal silica, methacryloyl silane, diacrylate, resorcinol monobenzoate and photoinitiator
US4491508A (en) * 1981-06-01 1985-01-01 General Electric Company Method of preparing curable coating composition from alcohol, colloidal silica, silylacrylate and multiacrylate monomer
US4486504A (en) * 1982-03-19 1984-12-04 General Electric Company Solventless, ultraviolet radiation-curable silicone coating compositions
US4522958A (en) * 1983-09-06 1985-06-11 Ppg Industries, Inc. High-solids coating composition for improved rheology control containing chemically modified inorganic microparticles
US4767726A (en) * 1987-01-12 1988-08-30 Minnesota Mining And Manufacturing Company Glass microbubbles
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
US5037579A (en) * 1990-02-12 1991-08-06 Nalco Chemical Company Hydrothermal process for producing zirconia sol
US5258225A (en) * 1990-02-16 1993-11-02 General Electric Company Acrylic coated thermoplastic substrate
JPH09512781A (ja) * 1994-04-25 1997-12-22 ミネソタ マイニング アンド マニュファクチャリング カンパニー 溶融された粒子を含む組成物及びその製造方法
DE19616781A1 (de) 1996-04-26 1997-11-06 Degussa Silanisierte Kieselsäure
DK0991415T3 (da) * 1997-12-22 2003-06-16 Schering Corp Faste, oralt indgivelige dosisformer for ribavirin og fremgangsmåde til fremstilling af disse
US6329058B1 (en) * 1998-07-30 2001-12-11 3M Innovative Properties Company Nanosize metal oxide particles for producing transparent metal oxide colloids and ceramers
GB9822523D0 (en) * 1998-10-15 1998-12-09 Courtaulds Coatings Holdings Powder coating compositions
GB9827145D0 (en) * 1998-12-09 1999-02-03 Co Ordinated Drug Dev Improvements in or relating to powders
US6585957B1 (en) * 2000-01-25 2003-07-01 Aeropharm Technology Incorporated Medicinal aerosol formulation
US7758888B2 (en) * 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
NZ526059A (en) * 2000-11-30 2005-05-27 Vectura Ltd Method of making composite active particles in the presence of an additive material for use in a pharmaceutical composition
US6586483B2 (en) * 2001-01-08 2003-07-01 3M Innovative Properties Company Foam including surface-modified nanoparticles
CN1263808C (zh) * 2001-02-27 2006-07-12 清华大学 一种微米颗粒表面纳米化改性方法
JP2005508939A (ja) * 2001-10-12 2005-04-07 エラン ファーマ インターナショナル，リミティド 即時放出および徐放特性を組み合わせて有する組成物
US7923030B2 (en) * 2003-03-14 2011-04-12 Sol-Gel Technologies, Inc. Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
US7459146B2 (en) * 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions

Similar Documents

Publication Publication Date Title
Weers et al. Formulation design of dry powders for inhalation
JP2013542940A5 (enExample)
HRP20210704T1 (hr) Formulacija suhog praška koja sadrži antikolinergik, kortikosteroid i beta-adrenergik za davanje inhalacijom
RU2010141331A (ru) Новая доза и препаративная форма
JP2009512663A5 (enExample)
JP2013224331A5 (enExample)
JP2012517987A5 (ja) 吸入用の医薬組成物のｆｐｄ特性を設定する方法
RU2010141333A (ru) Новая доза и препаративная форма
JP2014528470A5 (enExample)
JP2011520911A5 (enExample)
JP2015519356A5 (enExample)
JP2006526624A5 (enExample)
HK1203149A1 (en) Novel dosage form and formulation of abediterol
JP2002538110A5 (enExample)
AR067639A1 (es) Medicamentos pulverulentos que contienen tiotropio y salmetrol, asi como lactosa como excipiente
JP2005502675A5 (enExample)
UA107499C2 (uk) Склад сухого порошку, який містить антимускариновий засіб
WO2008084312A3 (en) Micronised particles of low-dosage strength active agents for powder formulations for inhalation
JP2013531056A5 (enExample)
JP2014530231A5 (enExample)
MY159172A (en) Inhalable particles comprising tiotropium
WO2006008517A3 (en) Use of dry powder compositions for pulmonary delivery
CA3199912A1 (en) Luminol for the prophylaxis and the treatment of sequelae of a sars-cov-2 infection
JP2007520507A5 (enExample)
MY187442A (en) A pharmaceutical composition containing budesonide and formoterol